Cargando…
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC), characterized by dense desmoplastic stroma laid down by pancreatic stellate cells (PSC), has no reliable diagnostic biomarkers for timely detection. A multi-center cohort of PDAC patients and controls (chronic pancreatitis, intra-ductal papillary neoplasms, g...
Autores principales: | Goulart, Michelle R., Watt, Jennifer, Siddiqui, Imran, Lawlor, Rita T., Imrali, Ahmet, Hughes, Christine, Saad, Amina, ChinAleong, Joanne, Hurt, Chris, Cox, Catrin, Salvia, Roberto, Mantovani, Alberto, Crnogorac-Jurcevic, Tatjana, Mukherjee, Somnath, Scarpa, Aldo, Allavena, Paola, Kocher, Hemant M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242009/ https://www.ncbi.nlm.nih.gov/pubmed/34188166 http://dx.doi.org/10.1038/s41698-021-00192-1 |
Ejemplares similares
-
Validation of a Novel, Flash‐Freezing Method: Aluminum Platform
por: Imrali, Ahmet, et al.
Publicado: (2020) -
Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017) -
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
por: Haider, Syed, et al.
Publicado: (2014) -
Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023) -
Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020)